Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Aliment Pharmacol Ther. 2014 Oct 27;41(1):99–107. doi: 10.1111/apt.12997

Figure 1.

Figure 1

Case ascertainment of IIDD in IBD patients with and without anti-TNFα exposure.

Inflammatory bowel disease (IBD), Crohn’s disease (CD), Ulcerative colitis (UC), anti-tumor necrosis factor alpha (anti-TNFα), idiopathic inflammatory-demyelinating disease of the central nervous system (IIDD)